Improving on nature: diversifying glycopeptide antibiotics to kill the bacterial pathogen Staphylococcus aureus

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1140619

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Many bacteria have become resistant to existing antibiotics and we are badly in need of new antibiotics and strategies to combat them. My research centres on the class of antibiotics that includes the last resort therapy vancomycin. I aim to (1) develop novel ways to kill bacteria with these antibiotics and (2) understand and re-engineer the ways in which these antibiotics are produced. This will allow my team will develop new antibiotics to kill dangerous bacteria such as Staphylococcus aureus.

Funded Activity Details

Start Date: 01-01-2018

End Date: 01-01-2021

Funding Scheme: Career Development Fellowships

Funding Amount: $476,728.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Biochemistry and Cell Biology not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Staphylococcus aureus | antibiotic resistance | antibiotics | drug discovery | innate immunity

Related Links